Cargando…

Zero fluoroscopy ablation for atrioventricular nodal reentrant tachycardia and typical atrial flutter is equally safe and effective with EnSite NavX, Carto3, and Rhythmia mapping systems

PURPOSE: Our purpose was to compare the procedural characteristics, success rate, and complication rate of the conventional fluoroscopic (CF) and the zero-fluoroscopic (ZF) approach in patients undergoing catheter ablation of AVNRT or typical atrial flutter (Aflu). METHODS: 186 consecutive patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Piros, Katalin, Perge, Péter, Salló, Zoltán, Herczeg, Szilvia, Nagy, Vivien Klaudia, Osztheimer, István, Merkely, Béla, Gellér, László, Szegedi, Nándor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407085/
https://www.ncbi.nlm.nih.gov/pubmed/37560116
http://dx.doi.org/10.3389/fcvm.2023.1185187
_version_ 1785085875899596800
author Piros, Katalin
Perge, Péter
Salló, Zoltán
Herczeg, Szilvia
Nagy, Vivien Klaudia
Osztheimer, István
Merkely, Béla
Gellér, László
Szegedi, Nándor
author_facet Piros, Katalin
Perge, Péter
Salló, Zoltán
Herczeg, Szilvia
Nagy, Vivien Klaudia
Osztheimer, István
Merkely, Béla
Gellér, László
Szegedi, Nándor
author_sort Piros, Katalin
collection PubMed
description PURPOSE: Our purpose was to compare the procedural characteristics, success rate, and complication rate of the conventional fluoroscopic (CF) and the zero-fluoroscopic (ZF) approach in patients undergoing catheter ablation of AVNRT or typical atrial flutter (Aflu). METHODS: 186 consecutive patients with an indication for AVNRT or Aflu ablation were enrolled. Based on the operator's preference, the patients were assigned to either CF or ZF group. In the ZF group EnSite NavX, Carto3, or Rhythmia EAMS were used for catheter guidance. RESULTS: The median age was 56 (IQR = 42−68) years, 144 patients had AVNRT, and 42 had Aflu ablation. CF approach was chosen in 123 cases, while ZF in 63 cases. ZF approach was used more often in case of AVNRT patients [56 (39%) vs. 7 (17%), p = 0.006] and in the case of female patients [43 (68%) vs. 20 (32%), p = 0.008]. Acute procedural success was obtained in all cases. There was no difference in the complication rate (1 vs. 1, p > 0.99) between the two groups. No difference was found regarding the procedure time between the CF and ZF groups [CF: 55 (46–60) min, ZF 60 (47–65) min; p = 0.487] or in the procedure time for the different EAMS [EnSite NavX: 58 (50–63) min, Carto3: 60 (44.5–66.3) min, Rhythmia: 55 (35–69) min; p = 0.887]. A similar success rate was seen at the 3-month follow-up in the two groups [41 (100%) vs. 96 (97%); p = 0.55]. DISCUSSION: The ZF approach demonstrated non-inferiority in safety and efficacy compared with CF for the AVNRT and Aflu ablations.
format Online
Article
Text
id pubmed-10407085
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104070852023-08-09 Zero fluoroscopy ablation for atrioventricular nodal reentrant tachycardia and typical atrial flutter is equally safe and effective with EnSite NavX, Carto3, and Rhythmia mapping systems Piros, Katalin Perge, Péter Salló, Zoltán Herczeg, Szilvia Nagy, Vivien Klaudia Osztheimer, István Merkely, Béla Gellér, László Szegedi, Nándor Front Cardiovasc Med Cardiovascular Medicine PURPOSE: Our purpose was to compare the procedural characteristics, success rate, and complication rate of the conventional fluoroscopic (CF) and the zero-fluoroscopic (ZF) approach in patients undergoing catheter ablation of AVNRT or typical atrial flutter (Aflu). METHODS: 186 consecutive patients with an indication for AVNRT or Aflu ablation were enrolled. Based on the operator's preference, the patients were assigned to either CF or ZF group. In the ZF group EnSite NavX, Carto3, or Rhythmia EAMS were used for catheter guidance. RESULTS: The median age was 56 (IQR = 42−68) years, 144 patients had AVNRT, and 42 had Aflu ablation. CF approach was chosen in 123 cases, while ZF in 63 cases. ZF approach was used more often in case of AVNRT patients [56 (39%) vs. 7 (17%), p = 0.006] and in the case of female patients [43 (68%) vs. 20 (32%), p = 0.008]. Acute procedural success was obtained in all cases. There was no difference in the complication rate (1 vs. 1, p > 0.99) between the two groups. No difference was found regarding the procedure time between the CF and ZF groups [CF: 55 (46–60) min, ZF 60 (47–65) min; p = 0.487] or in the procedure time for the different EAMS [EnSite NavX: 58 (50–63) min, Carto3: 60 (44.5–66.3) min, Rhythmia: 55 (35–69) min; p = 0.887]. A similar success rate was seen at the 3-month follow-up in the two groups [41 (100%) vs. 96 (97%); p = 0.55]. DISCUSSION: The ZF approach demonstrated non-inferiority in safety and efficacy compared with CF for the AVNRT and Aflu ablations. Frontiers Media S.A. 2023-07-25 /pmc/articles/PMC10407085/ /pubmed/37560116 http://dx.doi.org/10.3389/fcvm.2023.1185187 Text en © 2023 Piros, Perge, Salló, Herczeg, Nagy, Osztheimer, Merkely, Gellér and Szegedi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Piros, Katalin
Perge, Péter
Salló, Zoltán
Herczeg, Szilvia
Nagy, Vivien Klaudia
Osztheimer, István
Merkely, Béla
Gellér, László
Szegedi, Nándor
Zero fluoroscopy ablation for atrioventricular nodal reentrant tachycardia and typical atrial flutter is equally safe and effective with EnSite NavX, Carto3, and Rhythmia mapping systems
title Zero fluoroscopy ablation for atrioventricular nodal reentrant tachycardia and typical atrial flutter is equally safe and effective with EnSite NavX, Carto3, and Rhythmia mapping systems
title_full Zero fluoroscopy ablation for atrioventricular nodal reentrant tachycardia and typical atrial flutter is equally safe and effective with EnSite NavX, Carto3, and Rhythmia mapping systems
title_fullStr Zero fluoroscopy ablation for atrioventricular nodal reentrant tachycardia and typical atrial flutter is equally safe and effective with EnSite NavX, Carto3, and Rhythmia mapping systems
title_full_unstemmed Zero fluoroscopy ablation for atrioventricular nodal reentrant tachycardia and typical atrial flutter is equally safe and effective with EnSite NavX, Carto3, and Rhythmia mapping systems
title_short Zero fluoroscopy ablation for atrioventricular nodal reentrant tachycardia and typical atrial flutter is equally safe and effective with EnSite NavX, Carto3, and Rhythmia mapping systems
title_sort zero fluoroscopy ablation for atrioventricular nodal reentrant tachycardia and typical atrial flutter is equally safe and effective with ensite navx, carto3, and rhythmia mapping systems
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407085/
https://www.ncbi.nlm.nih.gov/pubmed/37560116
http://dx.doi.org/10.3389/fcvm.2023.1185187
work_keys_str_mv AT piroskatalin zerofluoroscopyablationforatrioventricularnodalreentranttachycardiaandtypicalatrialflutterisequallysafeandeffectivewithensitenavxcarto3andrhythmiamappingsystems
AT pergepeter zerofluoroscopyablationforatrioventricularnodalreentranttachycardiaandtypicalatrialflutterisequallysafeandeffectivewithensitenavxcarto3andrhythmiamappingsystems
AT sallozoltan zerofluoroscopyablationforatrioventricularnodalreentranttachycardiaandtypicalatrialflutterisequallysafeandeffectivewithensitenavxcarto3andrhythmiamappingsystems
AT herczegszilvia zerofluoroscopyablationforatrioventricularnodalreentranttachycardiaandtypicalatrialflutterisequallysafeandeffectivewithensitenavxcarto3andrhythmiamappingsystems
AT nagyvivienklaudia zerofluoroscopyablationforatrioventricularnodalreentranttachycardiaandtypicalatrialflutterisequallysafeandeffectivewithensitenavxcarto3andrhythmiamappingsystems
AT osztheimeristvan zerofluoroscopyablationforatrioventricularnodalreentranttachycardiaandtypicalatrialflutterisequallysafeandeffectivewithensitenavxcarto3andrhythmiamappingsystems
AT merkelybela zerofluoroscopyablationforatrioventricularnodalreentranttachycardiaandtypicalatrialflutterisequallysafeandeffectivewithensitenavxcarto3andrhythmiamappingsystems
AT gellerlaszlo zerofluoroscopyablationforatrioventricularnodalreentranttachycardiaandtypicalatrialflutterisequallysafeandeffectivewithensitenavxcarto3andrhythmiamappingsystems
AT szegedinandor zerofluoroscopyablationforatrioventricularnodalreentranttachycardiaandtypicalatrialflutterisequallysafeandeffectivewithensitenavxcarto3andrhythmiamappingsystems